
Janet Woodcock
Acting FDA Commissioner
Janet Woodcock is a career civil servant of the Food and Drug Administration (FDA) serving in various leadership roles at the FDA since 1986. In May 2020, Woodcock temporarily left her recent role as the Director of the Center for Drug Evaluation and Research of the FDA to head therapeutics initiatives for Operation Warp Speed amid the COVID-19 pandemic. Woodcock’s role was announced on January 20, 2021 and is listed on the FDA’s website. Woodcock is also reportedly under consideration as Biden’s potential pick for FDA Commissioner. Initial research provided insufficient information to allow EF to apply a rating to this candidate as of February 2, 2021.
Woodcock Was Reported As Acting Commissioner For The Food And Drug Administration On January 14, 2021


Previous Employment Of Note


Woodcock Expressed A Commitment To Using Evidence-Based Science


Woodcock Supported Using Evidence-Based Science During The FDA’s Approval Processes Of Plan B And Medication Abortion

